ArticleCancer2021
Delays in breast cancer care by race and sexual orientation: Results from a national survey with diverse women in the United States.
Article in Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Experiences and challenges of sexual and gender minority patients undergoing breast cancer treatment.American journal of surgery · 2026Article
- PRMT5/Sohlh2/Sirt1 Signaling Pathway in Vascular Endothelial Cells Modulates Lung Metastasis of Triple-Negative Breast Cancer.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Natural language processing to identify documented pain preceding radiation therapy for bone metastases.JNCI cancer spectrum · 2026Article
- "Pink is my least favorite color": experiences of sexual minority women and partners navigating breast cancer.Journal of psychosocial oncology · 2026Article
- Acceptability and Use of Digital Health and Artificial Intelligence-Enabled Chatbots for Sexual and Reproductive Health Among Lesbian, Bisexual, and Queer Women of Color in the United States: Cross-Sectional Survey Study.Journal of medical Internet research · 2025Article
- Breast Cancer Disparities in the LGBTQ + Community: How to Move Towards Inclusive Care from Screening to Survivorship.Current breast cancer reports · 2025Article
- Anticipated First Contact and Time to Seek Healthcare for Possible Breast Cancer Symptoms: A Cross-Sectional Study in Rural Ghana.Health expectations : an international journal of public participation in health care and health policy · 2025Article
- Addressing the gaps in cancer screening for LGBTQ+ individuals.Nature reviews. Cancer · 2025Article
- Affirming and effective sexual orientation and gender identity data collection: barriers, preferences, and recommendations from the community, clinicians, and staff.Journal of the National Cancer Institute. Monographs · 2025Article
- Nomogram for the prediction of the prognosis of patients with triple-negative invasive ductal carcinoma of breast after neoadjuvant chemotherapy.Scientific reports · 2025Article
- Applying the Intersectionality Lens to Understand Minority Ethnic Women's Experiences of the Breast Cancer Care Pathway in England: A Qualitative Interview Study.Psycho-oncology · 2025Article
- Culture, community, and cancer: understandings of breast cancer from a non-lived experience among women living in Soweto.BMC women's health · 2024Article
- Impact of microRNA variants on PI3K/AKT signaling in triple-negative breast cancer: comprehensive review.Medical oncology (Northwood, London, England) · 2024Review
- Targeted therapy approaches for epithelial-mesenchymal transition in triple negative breast cancer.Frontiers in oncology · 2024Review
- Engaging Black sexual minority women in breast cancer research: Lessons in community partnerships.Cancer · 2023Article
- Breast cancer disparities among sexual and gender minority populations.Translational cancer research · 2023Article
- Recent advances in targeted strategies for triple-negative breast cancer.Journal of hematology & oncology · 2023Review
- Cancer disparities among sexual and gender minority populations.Journal of the National Medical Association · 2023Article
- Article
- Relationship between intersectionality and cancer inequalities: a scoping review protocol.BMJ open · 2023Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
Abstract
backgroundDespite known differences in breast cancer by both race and sexual orientation, data on the intersectional experiences of Black sexual minority women (BSMW) along the care continuum are scant. This study sought to understand delays in breast cancer care by examining the intersection of race and sexual orientation.
methodsThis online, cross-sectional survey enrolled racially and sexually diverse women aged ≥ 35 years who had been diagnosed with breast cancer within the prior 10 years or had an abnormal screening in the prior 24 months. The authors calculated summary statistics by race/sexual orientation categories, and they conducted univariate and multivariable modeling by using multiple imputation for missing data.
resultsBSMW (n = 101) had the highest prevalence of care delays with 5.17-fold increased odds of a care delay in comparison with White heterosexual women (n = 298) in multivariable models. BSMW reported higher intersectional stigma and lower social support than all other groups. In models adjusted for race, sexual orientation, and income, intersectional stigma was associated with a 2.43-fold increase in care delays, and social support was associated with a 32% decrease in the odds of a care delay.
conclusionsIntersectional stigma may be an important driver of breast cancer inequities for BSMW. Reducing stigma and ensuring access to appropriate social support that addresses known barriers can be an important approach to reducing inequities in the breast cancer care continuum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.